BioInfra Co., Ltd. (KOSDAQ: 199730)

Market Cap	46.63B
Revenue	n/a
Net Income	n/a
Shares Out	4.80M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,788,805
Open	10,260
Previous Close	9,810
Day's Range	10,100 - 11,580
52-Week Range	7,000 - 13,910
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About BioInfra

Bioinfra Co., Ltd. operates as a contract research organization for phase 1 clinical trials. Its primary product is a bioequivalence test for generic drugs, a phase 1 test for incrementally modified drugs; and a phase 1 sample analysis for other new substances. The company was founded in 2007 and is based in Yongin-si, South Korea.

• Industry: Commercial Physical and Biological Research
• Founded: 2007
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 199730